Gene Testing Safely Spares Many Breast Cancer Patients from Chemotherapy

A transformative clinical trial led by University College London (UCL) has unveiled compelling evidence that numerous individuals diagnosed with hormone-sensitive breast cancer can safely circumvent chemotherapy by utilizing an advanced genomic testing approach. This finding heralds a significant shift in oncological treatment paradigms, potentially sparing thousands from the debilitating side effects associated with chemotherapy without […]
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment